Novanta - NOVT Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NOVT shares.
View NOVT analyst ratings or view top-rated stocks.

Novanta's stock was trading at $135.87 at the beginning of the year. Since then, NOVT shares have increased by 25.5% and is now trading at $170.58.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 1st 2023.
View our NOVT earnings forecast.

Novanta will be holding an earnings conference call on Wednesday, March 1st at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Novanta Inc. (NASDAQ:NOVT) posted its quarterly earnings data on Tuesday, November, 8th. The technology company reported $0.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.73 by $0.08. The technology company had revenue of $222.96 million for the quarter, compared to analysts' expectations of $215.01 million. Novanta had a trailing twelve-month return on equity of 20.16% and a net margin of 8.62%.

Novanta updated its first quarter 2023 earnings guidance on Tuesday, January, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $118.00 million-$122.00 million, compared to the consensus revenue estimate of $218.31 million.

44 employees have rated Novanta Chief Executive Officer Matthijs Glastra on Glassdoor.com. Matthijs Glastra has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Intuitive Surgical (ISRG), Lam Research (LRCX), Altria Group (MO), AT&T (T), Abiomed (ABMD), Advanced Micro Devices (AMD) and Broadcom (AVGO).

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

Novanta's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.92%), Allspring Global Investments Holdings LLC (2.91%), DekaBank Deutsche Girozentrale (0.42%), New York State Common Retirement Fund (0.40%), Exchange Traded Concepts LLC (0.35%) and Comerica Bank (0.35%). Insiders that own company stock include Brian S Young, Matthijs Glastra, Peter L Chang, Robert Buckley and Thomas N Secor.
View institutional ownership trends.

Shares of NOVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NOVT stock can currently be purchased for approximately $170.58.

Novanta (NASDAQ:NOVT) has a market capitalization of $6.09 billion and generates $706.79 million in revenue each year. The technology company earns $50.33 million in net income (profit) each year or $2.03 on an earnings per share basis.

The company employs 2,700 workers across the globe.

Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The official website for the company is www.novanta.com. The technology company can be reached via phone at (781) 266-5700, via email at investorrelations@novanta.com, or via fax at 781-266-5114.